QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
NYSE:CLVT

Clarivate (CLVT) Stock Forecast, Price & News

$7.24
+0.21 (+2.99%)
(As of 09/27/2023 ET)
Compare
Today's Range
$7.01
$7.26
50-Day Range
$6.60
$9.78
52-Week Range
$6.41
$11.99
Volume
7.90 million shs
Average Volume
6.08 million shs
Market Capitalization
$4.90 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.31

Clarivate MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
14.8% Upside
$8.31 Price Target
Short Interest
Bearish
12.94% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.55mentions of Clarivate in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
15.00%
From $0.60 to $0.69 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.24 out of 5 stars

Computer And Technology Sector

323rd out of 604 stocks

Data Processing & Preparation Industry

31st out of 60 stocks


CLVT stock logo

About Clarivate (NYSE:CLVT) Stock

Clarivate Plc, an information, analytics, and workflow company, provides structured information and analytics for discovery, development, protection, commercialization, and measurement of scientific research, innovations, and brands. The company operates through three segments: Academia and Government, Life Sciences and Healthcare, and Intellectual Property. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ProQuest One, Pivot, Polaris, eBook Central, Vegs, Alma, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis products for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs; and Real World Data, Dialog, Drug Safety Triager, and healthcare and data solutions. The company also provides Derwent products, which include Derwent Innovation, Innography, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; and CompuMark products, such as trademark screening, searching, and watching products and services. It serves government and academic institutions, and life science and healthcare companies in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

CLVT Price History

CLVT Stock News Headlines

Citigroup Trims Clarivate (NYSE:CLVT) Target Price to $8.00
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Clarivate Introduces Forecast, Its AI-driven Solution For IP Professionals
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Barclays Downgrades Clarivate (CLVT)
RBC Capital Downgrades Clarivate (CLVT)
Clarivate Reports Second Quarter 2023 Results
See More Headlines
Receive CLVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clarivate and its competitors with MarketBeat's FREE daily newsletter.

CLVT Company Calendar

Last Earnings
8/03/2023
Today
9/27/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Fax
N/A
Employees
11,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$8.31
High Stock Price Forecast
$11.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+15.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
8 Analysts

Profitability

Net Income
$-3,960,200,000.00
Net Margins
-159.90%
Pretax Margin
-165.83%

Debt

Sales & Book Value

Annual Sales
$2.66 billion
Cash Flow
$1.87 per share
Book Value
$8.04 per share

Miscellaneous

Free Float
522,256,000
Market Cap
$4.88 billion
Optionable
Optionable
Beta
1.15
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Jonathan Gear (Age 52)
    CEO & Director
    Comp: $1.3M
  • Mr. Jonathan M. Collins (Age 43)
    Exec. VP & CFO
    Comp: $1.96M
  • Mr. Gordon Samson (Age 57)
    Pres of Intellectual Property
    Comp: $1.02M
  • Mr. Michael Easton (Age 50)
    Sr. VP of Fin. & Chief Accounting Officer
  • Mr. William E. Graff
    Chief Information Officer
  • Mr. Mark J. Donohue
    Head of Investor Relations
  • Ms. Jaspal Chahal (Age 57)
    Chief Legal Officer & Gen. Counsel
  • Ms. Tabita Andersson
    Sr. VP of Communications & Brand
  • Ms. Julia M. Wilson (Age 60)
    Chief People Officer
  • Mr. Richard C. Finch
    Global Head of Life Sciences Consulting Services













CLVT Stock - Frequently Asked Questions

Should I buy or sell Clarivate stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Clarivate in the last year. There are currently 2 sell ratings, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CLVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLVT, but not buy additional shares or sell existing shares.
View CLVT analyst ratings
or view top-rated stocks.

What is Clarivate's stock price forecast for 2023?

8 analysts have issued 12-month price objectives for Clarivate's shares. Their CLVT share price forecasts range from $6.00 to $11.00. On average, they anticipate the company's share price to reach $8.31 in the next year. This suggests a possible upside of 15.3% from the stock's current price.
View analysts price targets for CLVT
or view top-rated stocks among Wall Street analysts.

How have CLVT shares performed in 2023?

Clarivate's stock was trading at $8.34 at the start of the year. Since then, CLVT stock has decreased by 13.5% and is now trading at $7.21.
View the best growth stocks for 2023 here
.

Are investors shorting Clarivate?

Clarivate saw a increase in short interest in September. As of September 15th, there was short interest totaling 53,720,000 shares, an increase of 6.4% from the August 31st total of 50,490,000 shares. Based on an average daily volume of 6,260,000 shares, the short-interest ratio is currently 8.6 days. Approximately 12.9% of the company's shares are short sold.
View Clarivate's Short Interest
.

When is Clarivate's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our CLVT earnings forecast
.

How were Clarivate's earnings last quarter?

Clarivate Plc (NYSE:CLVT) released its quarterly earnings data on Thursday, August, 3rd. The company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.19 by $0.02. The company had revenue of $668.80 million for the quarter, compared to analyst estimates of $673.97 million. Clarivate had a negative net margin of 159.90% and a positive trailing twelve-month return on equity of 9.65%. The company's revenue for the quarter was down 2.6% on a year-over-year basis. During the same period in the prior year, the company earned $0.19 EPS.

What ETF holds Clarivate's stock ?

iShares MSCI USA Size Factor ETF holds 68,505 shares of CLVT stock, representing 0.20% of its portfolio.

What guidance has Clarivate issued on next quarter's earnings?

Clarivate issued an update on its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of $0.77-$0.83 for the period, compared to the consensus EPS estimate of $0.83. The company issued revenue guidance of $2.60 billion-$2.67 billion, compared to the consensus revenue estimate of $2.68 billion.

What is Clarivate's stock symbol?

Clarivate trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLVT."

Who are Clarivate's major shareholders?

Clarivate's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Impactive Capital LP (4.23%), BlackRock Inc. (3.73%), Brahman Capital Corp. (1.65%), State Street Corp (1.39%), Invenomic Capital Management LP (0.99%) and Geode Capital Management LLC (0.95%). Insiders that own company stock include Andrew Miles Snyder, Blucher Sheryl G Von, Corp Onex, James Gordon Samson, Jeff Roy, Mukhtar Ahmed, Richard Hanks and Richard Roedel.
View institutional ownership trends
.

How do I buy shares of Clarivate?

Shares of CLVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Clarivate's stock price today?

One share of CLVT stock can currently be purchased for approximately $7.21.

How much money does Clarivate make?

Clarivate (NYSE:CLVT) has a market capitalization of $4.88 billion and generates $2.66 billion in revenue each year. The company earns $-3,960,200,000.00 in net income (profit) each year or ($6.37) on an earnings per share basis.

How many employees does Clarivate have?

The company employs 11,800 workers across the globe.

How can I contact Clarivate?

Clarivate's mailing address is 160 Blackfriars Road, London X0, SE1 8EZ. The official website for the company is www.clarivate.com. The company can be reached via phone at 442074334000 or via email at investor.relations@clarivate.com.

This page (NYSE:CLVT) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -